Blood signature of pre-heart failure: A microarrays study

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Smih, Fatima ^a   Desmoulin, Franck ^a   Berry, Matthieu ^a,b   Turkieh, Annie ^a   Harmancey, Romain ^a   Iacovoni, Jason ^a   Trouillet, Charlotte ^a,b   Delmas, Clement ^a,b   Pathak, Atul ^a,b   Lairez, Olivier ^a,b   Koukoui, François ^a   Massabuau, Pierre ^a,b   Ferrieres, Jean ^b   Galinier, Michel ^a,b   Rouet, Philippe ^a,b  

^a University Hospital of Toulouse   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; F BOX PROTEIN; F BOX PROTEIN AND WD REPEAT DOMAIN CONTAINING 7; FERROCHELATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMBRANE PROTEIN; MEMBRANE PROTEIN 79; NERVE GROWTH FACTOR BETA SUBUNIT; SOLUTE CARRIER FAMILY 43 MEMBER 2; UBINUCLEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEREDITY; HUMAN; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OBESITY; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; BIOLOGICAL MODEL; BLOOD; COMPUTER PROGRAM; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; RISK FACTOR;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; NATRIURETIC PEPTIDE, BRAIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SOFTWARE; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 79959592547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020414     Document Type: Article

References (34)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
2. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, et al. (2002) Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137: 631-639.
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-479.
4. McMurray JV, McDonagh TA, Davie AP, Cleland JG, Francis CM, et al. (1998) Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 19: 842-846.
5. Wang TJ, Levy D, Benjamin EJ, Vasan RS, (2003) The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138: 907-916.
6. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Porcellati C, (2005) Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value. Hypertension 45: 412-418.
7. Sharpe N, Murphy J, Smith H, Hannan S, (1990) Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction. Eur Heart J 11 (Suppl B): 147-156.
8. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327: 669-677.
9. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R, (2007) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 28: 1128-1134.
10. (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 327: 685-691.
11. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, et al. (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100: 1896-1901.
12. Yndestad A, Damas JK, Geir Eiken H, Holm T, Haug T, et al. (2002) Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 54: 175-182.
13. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, et al. (2009) Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics 38: 233-240.
14. Seiler PU, Stypmann J, Breithardt G, Schulze-Bahr E, (2004) Real-time RT-PCR for gene expression profiling in blood of heart failure patients-a pilot study: gene expression in blood of heart failure patients. Basic Res Cardiol 99: 230-238.
15. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA, (2006) The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147: 126-132.
16. Dabney AR, (2006) ClaNC: point-and-click software for classifying microarrays to nearest centroids. Bioinformatics 22: 122-123.
17. Varma S, Simon R, (2006) Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 7: 91.
18. Caporali A, Emanueli C, (2009) Cardiovascular actions of neurotrophins. Physiol Rev 89: 279-308.
19. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, et al. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350: 829-833.
20. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, et al. (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20: 447-455.
21. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, et al. (2001) Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358: 439-444.
22. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, et al. (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108: 977-982.
23. Daniels LB, Maisel AS, (2007) Natriuretic peptides. J Am Coll Cardiol 50: 2357-2368.
24. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, et al. (2005) Screening for heart disease in diabetic subjects. Am Heart J 149: 349-354.
25. Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, et al. (2009) The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail 15: 377-384.
26. Luers C, Wachter R, Kleta S, Uhlir M, Koschack J, et al. Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol 99: 217-226.
27. Quackenbush J, (2001) Computational analysis of microarray data. Nat Rev Genet 2: 418-427.
28. Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD, (2000) Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 86: E80-84.
29. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367.
30. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
31. Konig R, Baldessari D, Pollet N, Niehrs C, Eils R, (2004) Reliability of gene expression ratios for cDNA microarrays in multiconditional experiments with a reference design. Nucleic Acids Res 32: e29.
32. Philip-Couderc P, Pathak A, Smih F, Dambrin C, Harmancey R, et al. (2004) Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. Faseb J 18: 1539-1540.
33. Marshall OJ, (2004) PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20: 2471-2472.
34. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.